Opinion

Video

Switching Treatments in Spinal Muscular Atrophy

Key opinion leaders share their strategies for discussing potential changes in therapy and transitioning between treatments with patients, emphasizing the importance of reassuring patients that such changes are intended to provide long-term benefits for managing their spinal muscular atrophy.

Related Videos
Marcello Moccia, MD, PhD
Mikael Cohen, MD
Wallace Brownlee, MBChB, PhD, FRACP
Tom Fuchs, MD, PhD
Valentin Krüger, MD
Shamik Bhattacharyya, MD
Phillip Kuo, MD
Igor Koralnik, MD
© 2025 MJH Life Sciences

All rights reserved.